# US 2024/0197608 A1 · Acetyl sh-hexapeptide-5 amide acetate for use in the treatment of hair loss disorders and as a hair care agent

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197608 A1
- Document ID: US20240197608A1
- Status: Published application
- Kind: A1
- Application number: 18/287,116
- Filed: 2022-04-19
- Published: 2024-06-20
- Earliest claimed: 2021-04-20
- Applicants: Laboratorio Genove, S.A.
- Inventors: Nuria FLORIACH GUAL; Eva Maria ARIAS CHOUSA
- Web page: https://patentgrep.com/patent/US20240197608A1

## CPC

- A61K 8/64: Proteins; Peptides; Derivatives or degradation products thereof
- A61K 8/14: Liposomes; Vesicles
- A61K 9/127: Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K 38/06: Tripeptides
- A61K 38/08: Peptides having 5 to 11 amino acids {(A61K38/043 - A61K38/046 take precedence)}
- A61P 17/14: for baldness or alopecia
- A61Q 5/002: {Preparations for repairing the hair, e.g. hair cure}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The present invention relates to the therapeutic use of acetyl sh-hexapeptide-5 amide acetate, or a liposome thereof, or a pharmaceutical composition comprising it for use in the treatment of hair loss and also its cosmetic use as hair care agent; as well as processes for their preparation. The invention also relates to the therapeutic or cosmetic combination therapy of the acetyl sh-hexapeptide-5 amide acetate with tripeptide-10 citrulline; and a composition comprising acetyl sh-hexapeptide-5 amide acetate and tripeptide-10 citrulline.

## Claims

### Claim 1

A method for the treatment of a subject suffering from a hair loss disorder, wherein the method comprises administering to said subject
(a) a therapeutically effective amount of acetyl sh-hexapeptide-5 amide acetate, or a liposome thereof; or
(b) a pharmaceutical composition comprising a therapeutically effective amount of acetyl sh-hexapeptide-5 amide acetate, or a liposome thereof, together with one or more pharmaceutically acceptable excipients or carriers.

### Claim 2 (depends on 1)

The method for the treatment of claim 1, wherein the treatment is carried out in combination therapy with tripeptide-10 citrulline, or a liposome thereof.

### Claim 3 (depends on 1)

The method for the treatment of claim 1, wherein the method further comprises administering to said subject tripeptide-10 citrulline, or a liposome thereof.

### Claim 4 (depends on 3)

The method for the treatment according to claim 3, wherein the treatment comprises administering to a subject:
either
(a) a pharmaceutical composition comprising:
a therapeutically effective amount of acetyl sh-hexapeptide-5 amide acetate, or a liposome thereof; and
a therapeutically effective amount of tripeptide-10 citrulline, or a liposome thereof,
together with one or more pharmaceutically acceptable excipients or carriers;
or alternatively,
(b) simultaneously, sequentially or separately:
(b1) a pharmaceutical composition comprising a therapeutically effective amount of acetyl sh-hexapeptide-5 amide acetate, or a liposome thereof, together with one or more pharmaceutically acceptable excipients or carriers; and
(b2) a pharmaceutical composition comprising a therapeutically effective amount of tripeptide-10 citrulline or a liposome thereof, together with one or more pharmaceutically acceptable excipients or carriers.

### Claim 5 (depends on 1)

The method for the treatment according to claim 1, wherein the treatment is carried out by re-growing of the hair, by prevention of further hair loss, by diminishing the rate of hair loss, by reducing the telogen phase and increasing the anagen phase, and/or by enzymatic inhibition of 5-alpha reductase enzyme.

### Claim 6

A cosmetic method for hair care in a subject not suffering from a hair loss disorder, wherein the method comprises administering to said subject
(a) acetyl sh-hexapeptide-5 amide acetate, or a liposome thereof; or
(b) a cosmetic composition comprising a cosmetically effective amount of acetyl sh-hexapeptide-5 amide acetate, or a liposome thereof together with one or more cosmetically acceptable excipients or carriers; wherein the hair care comprises ameliorating at least one of the following symptoms: hair brittleness, hair thinning, hair breakage, lack of hair elasticity, lack of hair brightness, lack of hair volume, hair roughness, hair flaking, hair dehydration, reduction of hair density and hair dryness.

### Claim 7 (depends on 6)

The cosmetic method of claim 6, wherein the cosmetic method is carried out in combination therapy with tripeptide-10 citrulline, or a liposome thereof; wherein the hair care comprises ameliorating at least one of the following symptoms: hair brittleness, hair thinning, hair breakage, lack of hair elasticity, lack of hair brightness, lack of hair volume, hair roughness, hair flaking, hair dehydration, reduction of hair density and hair dryness.

### Claim 8 (depends on 6)

The cosmetic method of claim 6, wherein the method further comprises administering to said subject tripeptide-10 citrulline, or a liposome thereof; wherein the hair care comprises ameliorating at least one of the following symptoms: hair brittleness, hair thinning, hair breakage, lack of hair elasticity, lack of hair brightness, lack of hair volume, hair roughness, hair flaking, hair dehydration, reduction of hair density and hair dryness.

### Claim 9 (depends on 8)

The cosmetic method according to claim 8, wherein the cosmetic treatment comprises administering to a subject:
either
(c) a cosmetic composition comprising:
a cosmetically effective amount of acetyl sh-hexapeptide-5 amide acetate, or a liposome thereof; and
a cosmetically effective amount of tripeptide-10 citrulline or a liposome thereof,
together with one or more cosmetically acceptable excipients or carriers;
or alternatively,
(d) simultaneously, sequentially or separately:
(d1) a cosmetic composition comprising a cosmetically effective amount of acetyl sh-hexapeptide-5 amide acetate, or a liposome thereof, together with one or more cosmetically acceptable excipients or carriers; and
(d2) a cosmetic composition comprising a cosmetically effective amount of tripeptide-10 citrulline or a liposome thereof, together with one or more cosmetically acceptable excipients or carriers.

### Claim 10 (depends on 1)

The method for the treatment according to claim 1, wherein the treatment is administered once daily.

### Claim 11

A pharmaceutical or cosmetic composition comprising:
a therapeutically or cosmetically effective amount of acetyl sh-hexapeptide-5 amide acetate, or a liposome thereof; and
a therapeutically or cosmetically effective amount of tripeptide-10 citrulline, or a liposome thereof;
together with one or more pharmaceutically or cosmetically acceptable excipients or carriers.

### Claim 12 (depends on 11)

The pharmaceutical or cosmetic composition according to claim 11, which is a topical composition.

### Claim 13 (depends on 11)

The pharmaceutical or cosmetic composition according to claim 11, wherein the acetyl sh-hexapeptide-5 amide acetate is in a form of a liposome and the tripeptide-10 citrulline is in a form of a liposome.

### Claim 14 (depends on 11)

The pharmaceutical or cosmetic composition according to claim 11, wherein:
the one or more pharmaceutically or cosmetically acceptable excipients or carriers are selected from the group consisting of a vehicle, dispersing agent, viscosity controlling, pH adjuster, preservative, antioxidant, surfactant, emulsifier and a mixture thereof; and
the pharmaceutical or cosmetic composition further comprises one or more additional pharmaceutical or cosmetic active ingredients.

### Claim 15 (depends on 11)

The pharmaceutical or cosmetic composition according to claim 11, wherein: the effective amount of acetyl sh-hexapeptide-5 amide acetate is from 0.001% to 5% by weight; and the effective amount of tripeptide-10 citrulline is from 0.001% to 5% by weight.

### Claim 16 (depends on 3)

The method for the treatment according to claim 3, wherein the treatment is administered once daily.

### Claim 17 (depends on 3)

The method for the treatment according to claim 3, wherein the acetyl sh-hexapeptide-5 amide acetate is in a form of a liposome and the tripeptide-10 citrulline is in a form of a liposome.

### Claim 18 (depends on 6)

The cosmetic method according to claim 6, wherein the administration is once daily.

### Claim 19 (depends on 8)

The cosmetic method according to claim 8, wherein the administration is once daily.

### Claim 20 (depends on 8)

The pharmaceutical or cosmetic composition according to claim 8, wherein the acetyl sh-hexapeptide-5 amide acetate is in a form of a liposome and the tripeptide-10 citrulline is in a form of a liposome.
